BABA
Alibaba Group Holding Limited
BABA has the edge over TRIP overall, supported by lower modeled downside and stronger fundamentals.
TRIP
Tripadvisor, Inc.
TRIP offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
TRIP Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
TRIP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
TRIP PE Valuation
TRIP has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over TRIP on the outlook, with more favorable earnings and revenue expectations.
TRIP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect TRIP's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over TRIP on earnings quality, reporting a profit while its opponent remains loss making.
TRIP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.61 | — |
| Q3 2026 | -$3.07 | -565% |
| Q2 2026 | $0.02 | -96% |
| Q1 2026 | $0.11 | -72% |
| Q4 2025 | $0.31 | +675% |
| Q3 2025 | $0.66 | +164% |
| Q2 2025 | $0.50 | +194% |
| Q1 2025 | $0.39 | +129% |
| Q4 2024 | $0.04 | -50% |
TRIP has swung to a loss: it lost $3.07 per share over the past year, after a profit the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over TRIP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over TRIP on profitability, with a higher operating margin.
TRIP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.4M | -21% |
| Q2 2026 | $441.9M | -16% |
| Q1 2026 | $382.4M | -3.9% |
| Q4 2025 | $411M | 0% |
| Q3 2025 | $553M | +3.9% |
| Q2 2025 | $529M | +6.4% |
| Q1 2025 | $398M | +0.8% |
| Q4 2024 | $411M | +5.4% |
TRIP's revenue has slid since its 2025 peak: $436M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -77% | -90 points |
| Q2 2026 | 8.6% | -2.6 points |
| Q1 2026 | -6.6% | -2.8 points |
| Q4 2025 | -8.3% | -8.3 points |
| Q3 2025 | 13% | -0.5 points |
| Q2 2025 | 11% | +3.9 points |
| Q1 2025 | -3.8% | 0 points |
| Q4 2024 | 0% | -8.2 points |
TRIP's operating margin was −77% last quarter, down 90 points from the same quarter a year ago, near the bottom of its range since 2019.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
TRIP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$136.7M | -647% |
| Q2 2026 | $137.7M | -22% |
| Q1 2026 | $101.3M | +22% |
| Q4 2025 | -$122M | -$96M |
| Q3 2025 | $25M | +$88M |
| Q2 2025 | $177M | +392% |
| Q1 2025 | $83M | -33% |
| Q4 2024 | -$26M | +$9M |
TRIP has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
TRIP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -384K shares |
| 1 year | -5% | -6.2M shares |
| 3 years | -18% | -25.8M shares |
| 5 years | -19% | -27M shares |
| Available history | -16% | -23.2M shares |
TRIP has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $50M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $25M |
| Q3 2023 | — |
| Q4 2020 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
TRIP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
TRIP has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
TRIP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 9.6 | Oversold |
TRIP's weekly RSI is 32 (neutral) and its Stochastic is 10 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over TRIP on valuation relative to its sector.
TRIP PE vs Consumer Cyclical Sector
| Metric | TRIP | Sector median | Relative |
|---|---|---|---|
| PE | 461x | 18x | 2,458% above |
| PE % | 96 | 47 | 49 pts above |
TRIP has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
TRIP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.47 | 14% below |
| 20 week MA | $10.4 | 30% below |
| 50 week MA | $11.3 | 36% below |
| 100 week MA | $13.4 | 46% below |
| 200 week MA | $16.0 | 55% below |
TRIP is in a downtrend: it's below all five of its weekly moving averages, and 55% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over TRIP on returns for 2026, with the stronger performance.
TRIP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.3 | $26.0 | -14% |
| 2021 | $26.0 | $27.3 | +4.8% |
| 2022 | $27.3 | $17.9 | -35% |
| 2023 | $17.9 | $21.5 | +21% |
| 2024 | $21.5 | $14.6 | -32% |
| 2025 | $14.6 | $14.1 | -3.2% |
| 2026 YTD | $14.1 | $7.25 | -49% |
TRIP has finished lower in four of the last six years. It's down 49% so far in 2026.